Chapter 1: The evolution of cardiovascular treatment and death rate

In this video conversation series, Novartis Head of Global Drug Development and Chief Medical Officer Dr John Tsai and cardiologist Dr Steven Nissen discuss their perspectives and experiences around cardiovascular disease, the leading cause of death in the US. In Chapter 1 they speak about the evolution of cardiovascular treatment and death rate.

©2022 Novartis AG